NAN Alerts

Severe Burns and Permanent Scarring After Glacial Acetic Acid (≥ 99.5%) Mistakenly Applied Topically

Healthcare organizations should take immediate steps to ensure that only diluted acetic acid solutions are used in patient care. Eliminate the use and purchase of glacial acetic acid.

The Institute for Safe Medication Practices (ISMP), which operates the National Medication Errors Reporting Program, is warning healthcare providers about repeated incidents of accidental application of “glacial” acetic acid (≥ 99.5%) to skin or mucous membranes instead of a much more diluted form. Glacial acetic acid is the most concentrated form of acetic acid available. Inadvertent application of this corrosive chemical has led to severe burns, scarring, and other permanent damage to skin or mucous
membranes. The following are among the cases reported to ISMP:

  • A patient sustained severe burns and permanent scarring after glacial acetic acid (≥ 99.5%) was applied to her skin instead of a 5% acetic acid solution during a surgical procedure. The pharmacist was initially uncertain about dispensing the solution given that the label stated “Acetic Acid USP (Glacial),” but he later dispensed it without further dilution.

  • A nurse called the pharmacy for “acetic acid for irrigation” for a young woman with paraplegia, osteomyelitis, and bilateral greater trochanter wounds. An experienced pharmacist, yet new to the institution, placed glacial acetic acid at the window for pickup. This was used for 2 days instead of a diluted form. The undiluted solution resulted in burns to the extent that the wounds would not heal, necessitating disarticulation at the hips.

  • A physician in an ambulatory surgical center requested 4% acetic acid for use during anoscopy (similar to acetic acid use during a cervical colposcopy). Unit staff inadvertently purchased a bottle of glacial acetic acid directly from a medical supplier instead of the 4% solution. Although labeled “glacial acetic acid,” the solution was not further diluted. The patient suffered severe anal burns.

  • A nurse received glacial acetic acid from a pharmacy technician and poured the undiluted solution into a bowl on the sterile field in the operating room (OR).The surgeon was using acetic acid to identify rectal condyloma. He soaked a gauze pad and placed it in the patient’s rectum. The patient required extensive treatment and prolonged hospitalization due to tissue damage caused by the undiluted solution.

Diluted forms of acetic acid are used to treat certain infections of the outer ear and ear canal (2% solution),
or to identify cervical dysplasia during colposcopy or dysplasia of other mucous membranes (3-5%
solution; e.g., table vinegar is often used). A 0.25% sterile solution is commercially available and used for
its antimicrobial properties as a premixed irrigation, primarily for bladder installation or wounds.

A common factor in each case has been staff unfamiliarity with the term “glacial,” which refers to the
fact that, at its freezing point, pure acetic acid forms crystals that look like a glacier. Unfamiliarity with
“glacial” has led staff to order the wrong product from a supplier or use the product without knowledge
that further dilution is required.

glacial acetic acid
Figure 1. Label on glacial acetic acid bottle, front (L) and back label panels (R)

Glacial acetic acid is a chemical, which means it is not regulated by the US Food and Drug Administration
(FDA). Thus, label warnings are not standardized. While some containers have no warnings at all (Figure 1), other container labels carry a skull and crossbones with warnings about the product’s corrosiveness on
the side or back panel. Although the strength of the solution is generally listed on the label, it is easy to miss or can be misunderstood. For example, with the product in Figure 1, “99.5%” is hidden on the back panel and
has not been understood as the concentration because it is preceded by the word “assay.”

Take these steps to prevent this painful and harmful event:

Remove from stock. Remove glacial acetic acid from the pharmacy, discard it safely, and replace it with
vinegar (5% solution) or commercially available diluted acetic acid 0.25% (for irrigation) or 2% (for otic
use). Limit availability to these concentrations only. Ensure that the acid is not stored in clinical areas
such as the OR, clinics, physician practice sites, ambulatory surgical centers, and other procedural
areas. Glacial acetic acid has no use in its current form in clinical medicine.

Restrict purchasing. Rely on pharmacy to purchase acetic acid solutions for all procedural areas.

Restrict choices when purchasing. If using purchasing software, investigate the possibility of restricting
access to glacial acetic acid by creating approved “favorites” listings and/or making it invisible to purchasers
so it is not selected by mistake.

Ensure correct strength is ordered. Verify that the correct strength hasbeen requested from the vendor
and received in the pharmacy.

Educate staff. Ensure that all medical, pharmacy, nursing, and technical staff who prescribe,
dispense, use, or purchase products are aware of the differences between glacial acetic acid and
diluted forms of acetic acid.

Order 5% as “vinegar.” Physicians who perform colposcopy or anoscopy with 4% or 5% acetic acid can order it as “vinegar,” which may be used for this purpose. Ordering “vinegar” reduces the potential for confusion with glacial acetic acid. If vinegar will not suffice, it may be possible to purchase pre-diluted forms of acetic acid, which should then be diluted by pharmacy to the needed concentration and labeled.

Verify product. Require an independent double-check of acetic acid solutions before dispensing or applying the product.

As noted, product label shortcomings have contributed to the harm reported with glacial acetic acid. Current warnings may be totally absent, or inconsistent and inconspicuous. ISMP has contacted chemistry organizations to discuss these contributing factors in the hope that improved warning systems can be developed by the chemical industry.

More Alerts

We recently learned about three cases of accidental spinal injection of tranexamic acid instead of a local anesthetic intended for regional (spinal) anesthesia. Container mix-ups were involved in each case. In one case, a patient scheduled for knee surgery received tranexamic acid instead of
Medication use in the perioperative setting presents unique patient safety challenges compared with other hospital settings. For example, perioperative medication prescribing and administration often bypasses standard safety checks, such as electronic physician order entry with decision support